stella
beta
Risk Stratification and MRD-driven Maintenance for MM After ASCT — Stella
Home
/
Multiple Myeloma
/
Risk Stratification and MRD-driven Maintenance for MM After ASCT
View on ClinicalTrials.gov
Recruiting
Back to Multiple Myeloma trials
Risk Stratification and MRD-driven Maintenance for MM After ASCT
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(4 sites)
China
Fuxing Hospital, Beijing, Beijing Municipality
Peking Union Medical College Hospital, Beijing, Beijing Municipality
Peking University People's Hospital, Beijing, Beijing Municipality
The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang